Validation of the ERS standard citric acid cough challenge in healthy adult volunteers

Protocols measuring cough sensitivity can vary in terms of nebuliser, tussive agent, single and dose response. A definitive method for measuring cough sensitivity needs to be established.The ERS guidelines recommend the KoKo DigiDoser (KD) delivery system. Study aim, was to compare the reproducibility of this citric acid (CA) cough challenge and previously established Mefar dosimeter (MD) protocol.39 (female 26) volunteers mean age (40.4 yrs) were randomised to either KD or MD. Intra-day and inter-day reproducibility was compared.We calculated the concentration of citric acid evoking 2 coughs (C2).The geometric mean C2 (95%CI) was similar for both KD and MD, of 263 (200,339) mM and 209 (151,288) mM respectively.The mean KD C2 was not significantly different. (F = 0.807, p = 0.93) from baseline over 1, 2, and 4 hrs however, the MD demonstrated significant variability (F = 7.85, P < 0.001)Measuring mean log C2 at baseline and at 2 weeks, the KD demonstrated a stronger intraclass correlation of log C2 at baseline with 2 week log C2, ICC = 0.70 than was shown with the Mefar, ICC = 0.41Administering CA from KD offers a reproducible cough challenge in healthy volunteers. The results correlate well with the MD challenge but offer greater intra-day and inter-day reproducibility.

TRIAL REGISTRATION

Current controlled trials ISRCTN98385033.

Physical therapy management for adult patients undergoing cardiac surgery: a canadian practice survey

PURPOSE

To determine current Canadian physical therapy practice for adult patients requiring routine care following cardiac surgery.

METHODS

A telephone survey was conducted of a selected sample (n=18) of Canadian hospitals performing cardiac surgery to determine cardiorespiratory care, mobility, exercises, and education provided to patients undergoing cardiac surgery.

RESULTS

An average of 21 cardiac surgeries per week (range: 6-42) were performed, with an average length of stay of 6.4 days (range: 4.0-10.6). Patients were seen preoperatively at 7 of 18 sites and on postoperative day 1 (POD-1) at 16 of 18 sites. On POD-1, 16 sites performed deep breathing and coughing, 7 used incentive spirometers, 13 did upper-extremity exercises, and 12 did lower-extremity exercises. Nine sites provided cardiorespiratory treatment on POD-3. On POD-1, patients were dangled at 17 sites and mobilized out of bed at 13. By POD-3, patients ambulated 50-120 m per session 2-5 times per day. Sternal precautions were variable, but the lifting limit was reported as ranging between 5 lb and 10 lb.

CONCLUSIONS

Canadian physical therapists reported the provision of cardiorespiratory treatment after POD-1. According to current available evidence, this level of care may be unnecessary for uncomplicated patients following cardiac surgery. In addition, some sites provide cardiorespiratory treatment techniques that are not supported by evidence in the literature. Further research is required.

First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHC

Bose-Einstein correlations have been measured using samples of proton-proton collisions at 0.9 and 2.36 TeV center-of-mass energies, recorded by the CMS experiment at the CERN Large Hadron Collider. The signal is observed in the form of an enhancement of pairs of same-sign charged particles with small relative four-momentum. The size of the correlated particle emission region is seen to increase significantly with the particle multiplicity of the event.

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV

Charged-hadron transverse-momentum and pseudorapidity distributions in proton-proton collisions at square root of s = 7  TeV are measured with the inner tracking system of the CMS detector at the LHC. The charged-hadron yield is obtained by counting the number of reconstructed hits, hit pairs, and fully reconstructed charged-particle tracks. The combination of the three methods gives a charged-particle multiplicity per unit of pseudorapidity dN(ch)/dη|(|η|<0.5) = 5.78 ± 0.01(stat) ± 0.23(syst) for non-single-diffractive events, higher than predicted by commonly used models. The relative increase in charged-particle multiplicity from square root of s = 0.9 to 7 TeV is [66.1 ± 1.0(stat) ± 4.2(syst)]%. The mean transverse momentum is measured to be 0.545 ± 0.005(stat) ± 0.015(syst)  GeV/c. The results are compared with similar measurements at lower energies.

When are genetic methods useful for estimating contemporary abundance and detecting population trends?

The utility of microsatellite markers for inferring population size and trend has not been rigorously examined, even though these markers are commonly used to monitor the demography of natural populations. We assessed the ability of a linkage disequilibrium estimator of effective population size (N(e) ) and a simple capture-recapture estimator of abundance (N) to quantify the size and trend of stable or declining populations (true N = 100-10,000), using simulated Wright-Fisher populations. Neither method accurately or precisely estimated abundance at sample sizes of S = 30 individuals, regardless of true N. However, if larger samples of S = 60 or 120 individuals were collected, these methods provided useful insights into abundance and trends for populations of N = 100-500. At small population sizes (N = 100 or 250), precision of the N(e) estimates was improved slightly more by a doubling of loci sampled than by a doubling of individuals sampled. In general, monitoring N(e) proved a more robust means of identifying stable and declining populations than monitoring N over most of the parameter space we explored, and performance of the N(e) estimator is further enhanced if the N(e) /N ratio is low. However, at the largest population size (N = 10,000), N estimation outperformed N(e) . Both methods generally required ≥ 5 generations to pass between sampling events to correctly identify population trend.

Abstract A154: Mechanisms of cellular resistance to the growth inhibitory and cytotoxic effects of MDM2-p53 binding antagonists

Background: About 50% of solid tumors and more than 80% of haematological malignancies express wild-type p53 at diagnosis. Therefore, activation of the p53 pathway by antagonizing its negative regulator Murine Double Minute 2 (MDM2) may offer a new therapeutic strategy for cancer treatment. Recently, several potent and selective small molecule antagonists of the p53-MDM2 protein-protein interaction have been developed. Studies with these compounds have strengthened the concept that selective, non-genotoxic p53 activation may in some circumstances represent an alternative to current cytotoxic chemotherapy.

Aims: To investigate the potential for drug resistance against p53-MDM2 interaction antagonists and to establish therapeutic strategies to circumvent this.

Methods: NGP neuroblastoma and SJSA-1 osteosarcoma cell lines have been used to select a series of clonal variants resistant to two potent small molecule inhibitors of the MDM2-p53 interaction Nutlin-3 [Science 2004, 303, 844] and MI63 [J.Med.Chem. 2005, 48, 909]. The drug resistance phenotype of these clones was evaluated by SRB growth inhibition assay, western blotting for activation of p53 and downstream mediators of p53 dependent growth inhibition and cytotoxicity, and caspase-3/7 activation analysis, in response to drug treatment. DNA sequence analysis for p53 mutation detection was also conducted to explore possible resistance mechanisms.

Results: Following 60-day exposure to 1-5µM plus 60-day exposure to 5-40µM of MI63 or Nutlin-3 respectively, several clones were selected showing 11.5–43.2 fold increases in GI50 values. Clones selected for resistance to one of the agents showed cross-resistance to the other. This increased resistance was reflected in reduced activation of growth inhibition and apoptosis pathways downstream of p53, although induction of p53 protein itself was little changed compared to parental cell lines. All clones exhibited undetectable accumulation of MDM2 and p21 proteins compared with the marked changes seen with parental cells after treatment with 20 µM of Nutlin-3 or 5 µM MI63 for 4–6 hours, even though the p53 protein accumulated to the same extent as parental cells. Decreased cleavage of caspase-3 and PARP proteins were also observed, consistent with the reduced apoptosis. Caspase-3/7 enzymatic activity in the resistant clones in response to exposure to MI63 or Nutlin-3 for 48 hours was also significantly reduced compared to the response in parental cell lines. Point missense mutations of the p53 gene were observed within the resistant cell clones of both SJSA-1 and NGP cell lines.

Conclusions: As with other therapeutic agents, treatment with MDM2-p53 binding antagonists is likely to be subject to the development of drug resistance mechanisms. A panel of clones selected for resistance to Nutlin-3 and MI63 showed impaired activation of growth inhibitory and apoptotic pathways downstream of p53 in response to treatment with these agents compared to parental cells. DNA sequencing and p53 pathway analysis were consistent with a p53 mutation resistance mechanism.

Citation Information: Mol Cancer Ther 2009;8(12 Suppl):A154.

Conjugation of 2-(1'-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo

The carbohydrate moieties on conjugating with 3-(1'-hexyloxyethyl)-3-devinyl pyropeophorbide-a (HPPH) altered the uptake and intracellular localization from mitochondria to lysosomes. In vitro, HPPH-Gal 9 PDT showed increased PDT efficacy over HPPH-PDT as detectable by the oxidative cross-linking of nonphosphorylated STAT3 and cell killing in ABCG2-expressing RIF cells but not in ABCG2-negative Colon26 cells. This increased efficacy in RIF cells could at least partially be attributed to increased cellular accumulation of 9, suggesting a role of the ABCG2 transporter for which HPPH is a substrate. While such differences in the accumulation in HPPH derivatives by tumor tissue in vivo were not detectable, 9 still showed an elevated light dose-dependent activity compared to HPPH in mice bearing RIF as well as Colon26 tumors. Further optimization of the carbohydrate conjugates at variable treatment parameters in vivo is currently underway.

Sources of endocrine-disrupting chemicals in urban wastewater, Oakland, CA

Synthetic endocrine-disrupting chemicals (EDCs) have been found in surface waters throughout the United States, and are known to enter waterways via discharge from wastewater treatment plants (WWTPs). Studies addressing EDCs in wastewater do not examine their specific sources upstream of WWTPs. Presented here are results of a pilot study of potential sources of selected EDCs within an urban wastewater service area. Twenty-one wastewater samples were collected from a range of sites, including 16 residential, commercial, or industrial samples, and five samples from influent and effluent streams at the WWTP. Samples were analyzed for the following known and suspected EDCs: five phthalates, bisphenol A (BPA), triclosan, 4-nonylphenol (NP), and tris(2-chloroethyl) phosphate (TCEP), using well-established methods (EPA 625 and USGS O-1433-01). Twenty of 21 samples contained at least one EDC. Phthalates were widely detected; one or more phthalate compound was identified in 19 of 21 samples. Measurement of two phthalates in a field blank sample suggests that the accuracy of sample detections for these two compounds may be compromised by background contamination. Triclosan was detected in nine samples, BPA in five samples, and TCEP in four samples; NP was not detected. The results of this and future source-specific studies may be used to develop targeted pollution prevention strategies to reduce levels of EDCs in wastewater.

Investigation of molecular markers in the diagnosis of refractory coeliac disease in a large patient cohort: Table 1

Aims:

Some patients with coeliac disease, despite strict adherence to a gluten-free diet, continue to have significant symptoms and/or a severe small intestinal histological lesion. The term “refractory coeliac disease” (rCD) is used to describe this condition. The purpose of this study was to investigate the value of tissue molecular markers reported to help in the diagnosis of rCD.

Methods:

Details on 61 patients with suspected rCD were collected. The clinical and laboratory findings in these patients were carefully evaluated, in part to determine whether patients were adhering to a strict gluten-free diet. The co-expression of CD3 and CD8 on intraepithelial lymphocytes was investigated by monoclonal antibody staining of small intestinal biopsy tissue; a finding of less than 50% CD3+ cells co-expressing CD8 was defined as an aberrant phenotype. T cell receptor gene rearrangement was assessed when a sufficient tissue sample was available.

Results:

A diagnosis of rCD was made in 38 patients based on clinical, laboratory and histological data. An aberrant intraepithelial lymphocyte population was found in 20 of these patients and in this group a clonal T cell population was found in five of seven patients tested. In the remaining 18 patients, the CD3/CD8 ratio was normal and two of seven tested had a clonal T cell population. After detailed monitoring, a diagnosis of rCD was excluded in the remaining 23 patients.

Conclusions:

This study supports the use of phenotypic and T cell clonality investigations in identifying patients with true rCD.

Comparative expression analysis of four breast cancer subtypes versus matched normal tissue from the same patients

Gene expression studies have been widely used in an effort to identify signatures that can predict clinical progression of cancer. In this study we focused instead on identifying gene expression differences between breast tumors and adjacent normal tissue, and between different subtypes of tumor classified by clinical marker status. We have collected a set of 20 breast cancer tissues, matched with the adjacent pathologically normal tissue from the same patient. The cancer samples representing each subtype of breast cancer identified by estrogen receptor ER(+/-) and Her2(+/-) status and divided into four subgroups (ER+/Her2+, ER+/Her2-, ER-/Her2+, and ER-/Her2-) were hybridized on Affymetrix HG-133 Plus 2.0 microarrays. By comparing cancer samples with their matched normal controls we have identified 3537 overall differentially expressed genes using data analysis methods from Bioconductor. When we looked at the genes in common of the four subgroups, we found 151 regulated genes, some of them encoding known targets for breast cancer treatment. Unique genes in the four subgroups instead suggested gene regulation dependent on the ER/Her2 markers selection. In conclusion, the results indicate that microarray studies using robust analysis of matched tumor and normal samples from the same patients can be used to identify genes differentially expressed in breast cancer tumor subtypes even when small numbers of samples are considered and can further elucidate molecular features of breast cancer.

Increasing sucrose accumulation in sugarcane by manipulating leaf extension and photosynthesis with irrigation

High sucrose content (SC) in sugarcane stalks is a priority for all sugarcane industries world wide. Partitioning to sucrose in the cane stalk is related to the supply of photo-assimilate and the demand for assimilate by other organs. If photosynthesis could be maintained, but leaf and stalk growth constrained, by genetics or management during the stalk elongation phase, it may be possible to reduce stalk height and to increase both SC and sucrose yield. This paper reports an experiment designed to test this hypothesis and to develop a methodology to assess variation in response to source–sink manipulation in sugarcane clones. The research was conducted on a ‘low’ (Q138) and a ‘high’ (Q183) SC cultivar in two temperature controlled and airtight glasshouses (chambers) at CSIRO’s Davies Laboratory in Townsville, Australia. Potted plants of each cultivar were placed in two chambers of the Tall Plant Facility (TPF). In one chamber, plants were irrigated to minimise water stress while plants in the other chamber were irrigated to reduce plant extension rate (PER) considerably more than photosynthesis. Water stress reduced gain in total biomass by 19% and gain in top mass by 37%, and increased sucrose mass gain by 27%. During the experiment, SC of dry matter increased 37% in the dry treatment and only 8% in the wet treatment and this effect was greater in Q183 than in Q138. Water stress reduced whole plant photosynthesis by 18%, thus largely accounting for the 19% reduction in biomass accumulation and it reduced PER by 41%, corresponding to the 37% reduction in mass of tops. Reduced PER resulted in reduced demand for photo-assimilate by fibre and tops thus allowing excess assimilate to accumulate in the form of sucrose. The techniques developed here to control PER and measure the resulting changes in carbon partitioning now allow further examination of both the control of the balance between growth and sucrose storage and the extent of genotypic variation to the response of reduced PER.

Early identification of mental health needs for children in care: a therapeutic assessment programme for statutory clients of child protection

Infants, children and young people enter out of home care in distressing circumstances. They have often suffered traumatic experiences and have had their primary relationships disrupted. They and their families and carers have specific mental health needs at this time but few have attended a mental health service. A systematic comprehensive therapeutic assessment approach is described for all child protection clients who entered out-of-home care for the first time in one calendar year. The work of the programme is described using both case study and assessment findings. More than 60 per cent of participants met criteria for a major psychiatric diagnosis, with Post Traumatic Stress and Adjustment Disorders being the most common diagnostic categories. Nearly three-quarters of participants over the age of 5 years scored in the borderline or abnormal range on the Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997). There was an over-representation of infants less than 1 year of age and adolescents in the cohort, representing particular developmental challenges. The findings are discussed within the context of specific mental health service delivery to this vulnerable population of maltreated infants, children and young people.

The standard protein mix database: a diverse data set to assist in the production of improved Peptide and protein identification software tools

Tandem mass spectrometry (MS/MS) is frequently used in the identification of peptides and proteins. Typical proteomic experiments rely on algorithms such as SEQUEST and MASCOT to compare thousands of tandem mass spectra against the theoretical fragment ion spectra of peptides in a database. The probabilities that these spectrum-to-sequence assignments are correct can be determined by statistical software such as PeptideProphet or through estimations based on reverse or decoy databases. However, many of the software applications that assign probabilities for MS/MS spectra to sequence matches were developed using training data sets from 3D ion-trap mass spectrometers. Given the variety of types of mass spectrometers that have become commercially available over the last 5 years, we sought to generate a data set of reference data covering multiple instrumentation platforms to facilitate both the refinement of existing computational approaches and the development of novel software tools. We analyzed the proteolytic peptides in a mixture of tryptic digests of 18 proteins, named the "ISB standard protein mix", using 8 different mass spectrometers. These include linear and 3D ion traps, two quadrupole time-of-flight platforms (qq-TOF), and two MALDI-TOF-TOF platforms. The resulting data set, which has been named the Standard Protein Mix Database, consists of over 1.1 million spectra in 150+ replicate runs on the mass spectrometers. The data were inspected for quality of separation and searched using SEQUEST. All data, including the native raw instrument and mzXML formats and the PeptideProphet validated peptide assignments, are available at http://regis-web.systemsbiology.net/PublicDatasets/.

Fine-scale quantification of HCG beta gene transcription in human trophoblastic and non-malignant non-trophoblastic tissues

Human chorionic gonadotropin (HCG) is produced by syncytiotrophoblast of placenta. It delays the apoptosis of corpus luteum and functions in implantation. Its possible role in male reproduction has been raised. HCG beta subunit is encoded by CGB, CGB5, CGB7 and CGB8 genes located at 19q13.3 in a common genome cluster with beta subunit non-coding CGB1 and CGB2. We conducted a sensitive quantification and comparison of CGB gene expression in human trophoblastic (blastocysts, n = 6; normal/failed pregnancy, n = 51) and non-malignant non-trophoblastic tissues (15 different tissue types, samples n = 241), by real-time RT-PCR. We showed a wide transcriptional window of CGB genes in normal pregnancy, a significant reduction in recurrent miscarriages, and a high expression (especially CGB1/CGB2) in ectopic and molar pregnancies. Expression was several orders of magnitude lower in the non-placental tissues, with the highest CGB levels being seen in testis, prostate, thymus, skeletal muscle and lung samples. The contribution of CGB1/CGB2 to the summarized expression of six CGB genes was not proportional to their gene dosage: 1/1000 to 1/10,000. An interesting exception was the testis exhibiting a much higher CGB1/CGB2 to total CGB mRNA ratio of approximately one-third, corresponding to gene dosage. In conclusion, the expressional profile of CGB genes, activated already in blastocyst stage, is associated with the status of pregnancy. The presence of CGB transcripts in testes, and in particular CGB1/CGB2 transcripts, may indicate a role in male reproductive tract.

Distributions of the paralysis ticks Ixodes cornuatus and Ixodes holocyclus in south-eastern Australia

OBJECTIVE

To describe the actual and potential geographic distributions of Ixodes cornuatus and I holocyclus in south-eastern Australia.

PROCEDURE

Examination of ticks from museum collections and trapped animals were made. (Bioclimatic analysis BIOCLIM) was used to predict potential distributions.

RESULTS

I holocyclus was collected from rodents (Rattus fuscipes, R lutreolus, R rattus), wombats (Vombatus ursinus), cats and dogs in Gippsland and I cornuatus was collected from rodents (R fuscipes), wombats, cats and dogs in central Victoria. All life-cycle stages of both species were collected during the warmer months of the year. The known distribution of the two species was established from specimens in museum collections and suggested that a boundary between the two may exist in eastern Gippsland. BIOCLIM suggested that the area immediately to the east of Melbourne was climatically suitable for I holocyclus, although no endemic foci of infection are currently known from this region. The potential distribution of I cornuatus included east Gippsland and the Otway Ranges, areas in which the tick is not currently known to occur.

CONCLUSIONS

I holocyclus and I cornuatus have more restricted distributions than current collections suggest and therefore may have the possibility to extend their geographical ranges in the future.